Critical Contrast: Waystar (NASDAQ:WAY) and Firefly Neuroscience (NASDAQ:AIFF)

Firefly Neuroscience (NASDAQ:AIFF) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Firefly Neuroscience and Waystar, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1	0	0	0	1.00
Waystar	1	2	18	3	2.96

Waystar has a consensus price target of $35.23, indicating a potential upside of 45.39%. Given Waystar’s stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than Firefly Neuroscience.

Institutional and Insider Ownership

5.0% of Firefly Neuroscience shares are owned by institutional investors. 6.9% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 3.5% of Waystar shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Firefly Neuroscience and Waystar”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14 million	16.43	-$19.88 million	($0.63)	-1.90
Waystar	$1.10 billion	4.23	$112.09 million	$0.70	34.61

Waystar has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Firefly Neuroscience has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Waystar has a beta of 0.06, suggesting that its share price is 94% less volatile than the S&P 500.

Profitability

This table compares Firefly Neuroscience and Waystar’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-565.40%	-94.68%	-73.51%
Waystar	11.18%	7.03%	4.75%

Summary

Waystar beats Firefly Neuroscience on 11 of the 15 factors compared between the two stocks.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About Waystar

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.